Judith Lacey Clinical Oncology Society of Australia Annual Scientific Meeting 2017

Judith Lacey

Dr Judith Lacey is the Head of Supportive Care, director of Supportive Care and Integrative Oncology at Chris O’Brien Lifehouse . Her primary interest is in the development and integration of supportive care interventions to keep people living well with cancer independent of prognosis or stage of disease. Over the past 18 years she has worked extensively with cancer patients and people living with incurable illness. Her area of interest is in whole person care: integrating care for people and their families living with cancer or chronic illness that affects their physical and emotional well-being. She works with complementary and integrative medicine practitioners, psychologists, other medical specialists, nurses and allied health professionals to maximise patient wellbeing. As a Palliative and Supportive Care Specialist she has extensive experience in managing cancer pain syndromes, cancer related fatigue, gastrointestinal and nutritional effects of cancers and treatment related toxicities. She currently is the principle investigator on a multidisciplinary supportive care feasibility study to improve wellbeing of patients receiving immunotherapy with metastatic melanoma and leading research in integrative oncology and supportive cancer care at Chris O’Brien Lifehouse.. She is a member of the Multinational Association of Supportive Cancer Care, Society of Integrative Oncology, Sydney Catalyst Translational Cancer research centre, Australasian Lung Cancer Trials Group and Royal College of Physicians Medicinal Cannabis reference group. She has been involved in integration and policy development of palliative and supportive care services and more recently, integrative oncology in major health care systems in NSW. She has experience in both qualitative and quantitative research primarily in supportive cancer care. Her publications and research include: Integrative Oncology and Supportive Cancer Care, Coping with uncertainty and incurable cancer, symptom control and measuring QOL for the gynae-oncology patient, the role of the oncologist in care for the dying, palliative medicine as a public health issue, communication needs of cancer patients and couples and an associate investigator on a number of national studies evaluating medications and management of cancer related symptoms. She is a convenor and cofounder of the national whole person care program, workshops in Supportive Cancer Care and has held various expert advisory roles regarding palliative and supportive care service delivery and development for the cancer institute, cancer council and other bodies in Australia.

Abstracts this author is presenting: